ATE368737T1 - Kontrolle der genexpression durch verwendung eines komplexes aus einem oligonucleotid und einem regulatorischen peptid - Google Patents

Kontrolle der genexpression durch verwendung eines komplexes aus einem oligonucleotid und einem regulatorischen peptid

Info

Publication number
ATE368737T1
ATE368737T1 AT02801387T AT02801387T ATE368737T1 AT E368737 T1 ATE368737 T1 AT E368737T1 AT 02801387 T AT02801387 T AT 02801387T AT 02801387 T AT02801387 T AT 02801387T AT E368737 T1 ATE368737 T1 AT E368737T1
Authority
AT
Austria
Prior art keywords
gene expression
molecule
nucleic acid
methods
modulating
Prior art date
Application number
AT02801387T
Other languages
English (en)
Inventor
Stephen Hart
Simak Ali
Boris Pufong
Andrew Porter
Laki Buluwela
Satu Vainikka
John Jenkinson
Patrick Kanda
Original Assignee
Imp Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9923615&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE368737(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Imp Innovations Ltd filed Critical Imp Innovations Ltd
Application granted granted Critical
Publication of ATE368737T1 publication Critical patent/ATE368737T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01048—Histone acetyltransferase (2.3.1.48)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3513—Protein; Peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02801387T 2001-10-11 2002-10-11 Kontrolle der genexpression durch verwendung eines komplexes aus einem oligonucleotid und einem regulatorischen peptid ATE368737T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0124391.4A GB0124391D0 (en) 2001-10-11 2001-10-11 Control of gene expression

Publications (1)

Publication Number Publication Date
ATE368737T1 true ATE368737T1 (de) 2007-08-15

Family

ID=9923615

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02801387T ATE368737T1 (de) 2001-10-11 2002-10-11 Kontrolle der genexpression durch verwendung eines komplexes aus einem oligonucleotid und einem regulatorischen peptid

Country Status (11)

Country Link
EP (1) EP1470226B1 (de)
AT (1) ATE368737T1 (de)
AU (1) AU2002334142B2 (de)
CA (1) CA2474216C (de)
CY (1) CY1107754T1 (de)
DE (1) DE60221572T2 (de)
DK (1) DK1470226T3 (de)
ES (1) ES2291536T3 (de)
GB (2) GB0124391D0 (de)
PT (1) PT1470226E (de)
WO (1) WO2003033701A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2508052A1 (en) * 2002-12-05 2004-06-17 Imperial College Innovations Limited Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide
NL1027311C2 (nl) * 2004-10-21 2006-05-01 Synvolux Ip B V Vehikel voor transport van een DNA-modificerend enzym naar een genoom.
NL1027479C2 (nl) * 2004-10-21 2006-05-01 Synvolux Ip B V Bescherming van biologisch actieve moleculen met behulp van amphifielen.
IL296832A (en) 2005-10-18 2022-11-01 Nat Jewish Health Process of preparing red blood cells using conditionally immortalized long-term hematopoietic stem cells and erythropoietin
SG10201803982TA (en) 2008-05-16 2018-07-30 Taiga Biotechnologies Inc Antibodies and processes for preparing the same
DK3339321T3 (da) 2008-08-28 2021-06-21 Taiga Biotechnologies Inc Modulatorer af myc, fremgangsmåder til anvendelse af samme og fremgangsmåder til at identificere stoffer der modulerer myc
AU2011263642B2 (en) 2010-06-11 2014-09-04 Isarna Therapeutics Gmbh Method for selective oligonucleotide modification
US9789135B2 (en) 2012-07-20 2017-10-17 Taiga Biotechnologies, Inc. Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
US9365825B2 (en) 2013-03-11 2016-06-14 Taiga Biotechnologies, Inc. Expansion of adult stem cells in vitro
US10272115B2 (en) 2013-03-11 2019-04-30 Taiga Biotechnologies, Inc. Production and use of red blood cells
US9758786B2 (en) 2016-02-09 2017-09-12 Autotelic, Llc Compositions and methods for treating pancreatic cancer
EP3548425B1 (de) 2016-12-02 2023-03-29 Taiga Biotechnologies, Inc. Nanopartikelformulierungen
WO2018232356A1 (en) 2017-06-15 2018-12-20 The Regents Of The University Of California Targeted non-viral dna insertions
US10149898B2 (en) 2017-08-03 2018-12-11 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma
JP7101419B2 (ja) 2017-10-27 2022-07-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 内因性ｔ細胞受容体の標的置換
CN113874033A (zh) 2019-04-08 2021-12-31 泰加生物工艺学公司 用于冷冻保存免疫细胞的组合物和方法
EP3969041A4 (de) 2019-05-14 2023-05-10 Taiga Biotechnologies, Inc. Zusammensetzungen und verfahren zur behandlung von t-zell-erschöpfung
JP2024537991A (ja) 2021-10-14 2024-10-18 アーセナル バイオサイエンシズ インコーポレイテッド 共発現されるｓｈＲＮＡと論理ゲートシステムとを有する免疫細胞

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000002019A1 (en) * 1998-07-02 2000-01-13 Industrial Research Limited A coriolis effect fluid flow meter
GB9718609D0 (en) * 1997-09-02 1997-11-05 Imp College Innovations Ltd Fusion protein
AU1395999A (en) * 1997-11-10 1999-05-31 Salk Institute For Biological Studies, The Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases
GB9915126D0 (en) * 1999-06-30 1999-09-01 Imp College Innovations Ltd Control of gene expression
CA2316036A1 (en) * 1999-08-27 2001-02-27 Keqiang Wu Repressing gene expression in plants
WO2001059094A2 (en) * 2000-02-11 2001-08-16 The Salk Institute For Biological Studies Method of regulating transcription in a cell by altering remodeling of cromatin

Also Published As

Publication number Publication date
DE60221572D1 (de) 2007-09-13
GB0223605D0 (en) 2002-11-20
ES2291536T3 (es) 2008-03-01
GB2382581A (en) 2003-06-04
DK1470226T3 (da) 2007-12-10
EP1470226B1 (de) 2007-08-01
EP1470226A1 (de) 2004-10-27
PT1470226E (pt) 2007-11-02
WO2003033701A1 (en) 2003-04-24
DE60221572T2 (de) 2008-04-17
GB0124391D0 (en) 2001-11-28
CY1107754T1 (el) 2013-04-18
CA2474216C (en) 2012-03-13
AU2002334142B2 (en) 2007-12-13
CA2474216A1 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
CY1107754T1 (el) Ελεγχος γονιδιακης εκφρασης χρησιμοποιωντας συμπλεγμα ολιγονουκλεοτιδιου και ρυθμιστικου πεπτιδιου
Nair et al. Chromatin dynamics in genome stability: roles in suppressing endogenous DNA damage and facilitating DNA repair
DE59712890D1 (de) Neues gen für eine aminosäure-deacetylase mit spezifität für n-acetyl-l-phosphinothricin, ihre isolierung und verwendung
JP2004504001A (ja) スプライソソーム媒介ｒｎａトランスースプライシングにおける使用のための方法及び組成物
DE69831224D1 (de) Immuntoxine, die ein onc protein enthalten, gegen bösartige zellen
Pan et al. Structural and functional basis of JAMM deubiquitinating enzymes in disease
DK0941318T3 (da) Håndvægtformede konstruerede ekspressionssystemer til genterapi
EP1229134A3 (de) Verwendung von post-transkriptioneller Genabschaltung zur Identifizierung von Nukleinsäuresequenzen die die Funktion einer Zelle beeinflussen
HUP0003533A2 (hu) Interleukin-18-at kötő fehérjék, előállításuk és alkalmazásuk
DK1641818T3 (da) Polypeptider der har bindingsaffinitet for HER2
DE60214867D1 (en) Histonedeacetylase 9
WO2003095608A3 (en) Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
WO2004050885A3 (en) Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide
WO2004050680A3 (en) Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
MXPA03009323A (es) Moleculas de acido nucleico que se relacionan a maduracion de papaya.
DE60322882D1 (de) T zell-subpopulation zur regelung der darmimmunität
J. Verheul et al. Targeted protein degradation as a promising tool for epigenetic upregulation of fetal hemoglobin
Farrugia et al. Analysis of a soluble (UreD: UreF: UreG) 2 accessory protein complex and its interactions with Klebsiella aerogenes urease by mass spectrometry
EP2261362A3 (de) Verfahren zur besserung der architektur und des ertrags von getreide pflanzen
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
WO2007026355A3 (en) Modulators of cell migration and methods of identifying same
WO1995030009A3 (en) Identification, production and use of saponin glyclosyl hydrolases
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
Leahy et al. Discrimination of methionine sulfoxide and sulfone by human neutrophil elastase
Qiao et al. Site-specific hydrolysis of horse heart cytochrome c and apocytochrome c promoted by palladium (II) complex

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1470226

Country of ref document: EP